Skip to main content
Fig. 5 | Molecular Neurodegeneration

Fig. 5

From: Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery

Fig. 5

The equilibrium model of deleterious and protective factors during AD disease progression. Among the biological processes and cellular pathways activated at the asymptomatic stage of AD, some may exert protective roles. However, with exacerbation of the harmful insults during disease progression, the protective effect is exhausted. The resulting imbalance leads to neuronal degeneration and the onset of clinical symptoms. The pathway information is extracted from current AD proteomic studies [74, 75, 78, 161]

Back to article page